Endoscopic submucosal dissection for rectal neuroendocrine tumours: A multicentric retrospective study
Alessandro Rimondi,Edward J Despott,Rocio Chacchi,Nikolaos Lazaridis,Deborah Costa,Ana-Maria Bucalau,Dalvinder Mandair,Mathieu Pioche,Jérome Rivory,Joao Santos-Antunes,Margarida Marques,Felipe Ramos-Zabala,Federico Barbaro,Pedro Pimentel-Nunes,Mario Dinis-Ribeiro,Eduardo Albeniz,Marcel Tantau,Cristiano Spada,Arnaud Lemmers,Martyn Caplin,Christos Toumpanakis,Alberto Murino
DOI: https://doi.org/10.1016/j.dld.2024.04.033
IF: 5.165
2024-05-21
Digestive and Liver Disease
Abstract:Introduction Endoscopic Submucosal Dissection (ESD) has been reported as a feasible and effective treatment for Rectal Neuroendocrine Tumours (R-NETs). However, most of the experience on the topic comes from retrospective tertiary centre from Eastern Asia. Data on ESD for R-NETs in Western centres are lacking. Materials and Methods This is a retrospective study, including patients who underwent endoscopic resection of R-NETS by ESD between 2015 and 2020 in Western Centres. Important clinical variables such as demographic, size of R-NETs, histological type, presence of lymphovascular invasion or distant metastasis, completeness of the endoscopic resection, recurrence, and procedure related complications were recorded. Results 40 ESD procedure on R-NETs from 39 patients from 8 centres were included. Mean R-NETs size was 10.3 mm (SD 4.01). Endoscopic en-bloc resection was achieved in 39/40 ESD (97.5 %), R0 margin resection was obtained in 87.5 % (35/40) of the procedures, one patient was referred to surgery for lymphovascular invasion, two procedures (5 %) reported significant episodes of bleeding, whereas a perforation occurred in one case (1/40, 2.5 %) managed endoscopically. Recurrence occurred in 1 patient (2.5 %). Conclusion ESD is an effective and safe treatment for R-NETs in western centres.
gastroenterology & hepatology